FILE PHOTO: A Philip Morris logo is pictured on a factory in Serrieres near Neuchatel, Switzerland December 8, 2017/File Photo
August 8, 2021
(Reuters) – Philip Morris has raised its bid for British drugmaker Vectura to 165 pence ($2.29) per share, the tobacco company said on Sunday.
“The PMI (Philip Morris International) increased offer values the entire issued and to be issued ordinary share capital of Vectura at approximately 1.02 billion pounds ($1.41 billion),” it said in an emailed statement to Reuters.
The latest offer represents a premium of approximately
10 pence per share to a rival offer of 155 pence a share by U.S.-based Carlyle Group announced on Friday.
Carlyle offered to buy Vectura for about 958 million pounds ($1.3 billion).
Vectura, which makes respiratory treatments, had said on Friday that it was backing Carlyle’s offer and withdrawing its recommendation for Philip Morris’ proposal, adding that it might be better positioned under Carlyle’s ownership.
Vectura did not immediately respond to a Reuters request for comment.
($1 = 0.7209 pounds)
(Reporting by Vishal Vivek in Bengaluru; Editing by Andrew Cawthorne and Raissa Kasolowsky)
Source: One America News Network
